Director, Tech Transfer

Define and continuously evolve the global Tech Transfer strategy covering established process and analytical methods aligned with portfolio, lifecycle, and manufacturing network priorities. Establish and govern standardized frameworks, methodologies, and best practices for Tech Transfer. Provide strategic input to manufacturing footprint, capacity planning, and long-term operational strategy. Own end-to-end accountability for global Tech Transfer execution including process and analytical methods, ensuring delivery against quality, cost, and timeline targets. Oversee transfer strategies, risk assessments, and comparability approaches, ensuring validation readiness and PPQ alignment. Ensure complete, effective knowledge transfer and documentation across sending and receiving units. Provide senior technical oversight to ensure process robustness, scalability, and consistency across transfers and lifecycle changes. Ensure integration of QbD principles and control strategies into transfer execution. Lead resolution of complex technical challenges, including scale-up issues, facility fit gaps, and deviations. Lead identification, selection, and oversight of CMOs, CROs, and external partners supporting Tech Transfer. Conduct technical due diligence and capability assessments for new manufacturing sites and partnerships. Ensure external partner performance meets agreed quality, compliance, and delivery standards. Ensure seamless collaboration across Process Development, Manufacturing, MS&T;, QC, QA, and Engineering. Align development, clinical, and commercial organizations on transfer readiness and execution strategy. Facilitate structured communication across global stakeholders to ensure alignment and risk mitigation. Define and monitor Tech Transfer KPIs (e.g., right-first-time, cycle time, deviation rates). Drive structured resolution of transfer risks, deviations, and performance gaps. Implement performance oversight and continuous improvement initiatives, including digital and innovative solutions.

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

• Postgraduate degree (PhD preferred) in Life Sciences, Engineering, or related discipline.

• Extensive experience (typically 12+ years) in biopharmaceutical development, manufacturing, or Tech Transfer.

• Proven leadership of complex global Tech Transfer programs across sites and external partners.

• Strong understanding of technology transfer, scale-up, process validation, and regulatory requirements.

• Demonstrated ability to lead large, cross-functional, matrixed organizations.

• Strong track record in external partner management and manufacturing network collaboration.

• Excellent strategic thinking, stakeholder management, and influencing skills.

• Experience in global, multicultural environments.